Changes in endogenous levels of phospholipid arachidonic acid and in its radioactive incorporation can be detected in the rat kidney medulla during maturation. In an effort to explain this phenomenon, the arachidonoyl-CoA synthetase activity in the neonatal (10 days of age) and adult kidney (70-day-old rats) were studied. The neonatal kidney enzyme showed greater affinity, but less capacity than the adult enzyme to incorporate arachidonic acid into the membrane. The apparent Km values were 27.8 and 73.9 µM while the vmax was 3.68 and 15.7 nmol/min/mg protein, for 10 and 70 days of age, respectively. Affinity for ATP was found to be almost 7-fold greater in adults when compared to neonates. The vmax for ATP also increased during development, with values of 1.04 and 2.87 at 10 and 70 days of age, respectively. Affinity for coenzyme A did not vary between the two stages studied, though the vmax increased 10-fold from 10 to 70 days of age. Since arachidonic acid availability is low in the perinatal stage because of its restricted endogenous synthesis, the higher enzyme affinity for this fatty acid at 10 days of age described here, could be of great importance in helping to capture the low but indispensable amount of arachidonic acid present in maternal milk during lactation.

Keywords:
Arachidonoyl-CoA synthetase, Development
This content is only available via PDF.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.